(Q39507725)

12 September 2017

Systemic lupus erythematosus and lymphoma. (English)

1 reference

systemic lupus erythematosus

12 September 2017

0 references

author name string

J A Green

series ordinal

1

1 reference

12 September 2017

A A Dawson

series ordinal

2

1 reference

12 September 2017

W Walker

series ordinal

3

1 reference

12 September 2017

language of work or name

English

0 references

publication date

1 October 1978

1 reference

12 September 2017

1 reference

12 September 2017

2

1 reference

12 September 2017

753-756

1 reference

12 September 2017

8093

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2878%2992645-4

12 September 2017

1 reference

7 January 2021

Hodgkin's disease associated with other malignant tumors and certain non-neoplastic diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2878%2992645-4

7 January 2021

THE DEVELOPMENT OF MALIGNANT LYMPHOMA IN THE COURSE OF SJOEGREN'S SYNDROME

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2878%2992645-4

7 January 2021

The association of immune disease and malignant lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2878%2992645-4

7 January 2021

Systemic Rheumatic Disease and Malignant Lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2878%2992645-4

7 January 2021

Malignancy in a series of 70 patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2878%2992645-4

7 January 2021

Occurrence of malignancy in immunodeficiency diseases. A literature review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2878%2992645-4

7 January 2021

Immunoregulation, oncogenic viruses, and malignant lymphomas.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2878%2992645-4

7 January 2021

Pathogenesis of autoimmunity in New Zealand mice. V. Loss of thymic suppressor function

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2878%2992645-4

7 January 2021

Diagnostic import of virus-like particles in the glomerular endothelium of patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2878%2992645-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS0140-6736%2878%2992645-4

1 reference

7 January 2021

Immunopathogenicity and oncogenicity of murine leukemia viruses. I. Induction of immunologic disease and lymphoma in (BALB-c times NZB)F1 mice by Scripps leukemia virus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2878%2992645-4

7 January 2021

Risk of cancer in renal-transplant recipients.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2878%2992645-4

7 January 2021

Immunoblastic lymphadenopathy. A hyperimmune entity resembling Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2878%2992645-4

7 January 2021

Angio-immunoblastic lymphadenopathy. Diagnosis and clinical course

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2878%2992645-4

7 January 2021

Appearance of Hodgkin's disease in a patient with systemic lupus erythematosus.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2878%2992645-4

7 January 2021

Type I dysgammaglobulinemia, systemic lupus erythematosus and lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2878%2992645-4

7 January 2021

Systemic lupus erythematosus and neoplasia of the lymphoreticular system

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2878%2992645-4

7 January 2021

Development of malignant cerebral lymphoma in a patient with systemic lupus erythematosus treated with immunosuppression

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2878%2992645-4

7 January 2021

10.1016/S0140-6736(78)92645-4

Identifiers

DOI

1 reference

release_fd7zv374rrh4vevhd2icdtwjau

12 September 2017

0 references

1 reference